Feedback / Questions
LB-P8 - LISCure Biosci, Mayo Clinic
https://www.prnewswire.com/news-releases/liscure-biosciences-receives-us-fda-fast-track-designation-for-lb-p8-for-the-treatment-of-primary-sclerosing-cholangitis-psc-302102626.html
Mar 29, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next